Breast cancer is a major health problem. Clinical heterogeneity makes prognosis and sensitivity to treatment highly variable among patients. The recently developed cDNA array technology allows to analyse the expression of thousands of genes simultaneously. Results of the pioneering studies are promising: expression profiling of breast tumours using cDNA arrays seems able to identify new prognostic sub-classes unidentifiable using conventional parameters.